Atlanta, GA 5/14/12 (StreetBeat) -- BMC Software Inc (Nasdsaq: BMC) adopted a shareholder rights plan to help stave off a potential acquisition, after hedge fund group Elliott called for a sale of the company and told the business software maker it acquired a more than 5 percent stake.
Elliott Associates LP and Elliott International LP, which together hold the stake, plan to nominate a five-member slate to its board, BMC said on Monday.
New York-based Elliott, an activist hedge fund, often urges companies to sell themselves and sometimes starts proxy fights to elect its own representative to the board.
BMC - which makes software for storage management, database performance and data recovery - adopted a poison pill with a 10 percent trigger, giving one right to each outstanding share and will expire on May 11, 2013, unless renewed.
Shares of BMC Software, which have lost nearly a quarter of their value in the past year, were up 4 percent at $41.96 in premarket trading. They closed at $40.40 on Friday on the Nasdaq.
Dodge & Cox, Columbia Management Investment Advisers LLC, Vanguard Group Inc and BlackRock Institutional Trust Co also hold at least 5 percent each in BMC.
BMC's board rejected Elliott's proposal to sell the company and said it was not in the best interest of the stockholders, the company said in a statement on Monday.
Morgan Stanley is the financial adviser and Wachtell, Lipton, Rosen & Katz is the legal counsel to BMC.
BMC, which offers software and cloud platforms that help businesses cut costs by allocating resources better, is valued at $6.5 billion.
Last week it posted a 21 percent increase in revenue from professional services, and its bookings in cloud-related licensing rose.
Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail email@example.com or call (662) 392-0740 for pricing and scheduling.